SMITHER JOHN W (Chief Financial Officer) received a stock award from SIENNA BIOPHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/3/2019ACC: 0001562180-19-000149
Officer· Chief Financial Officer
Since Jul 2018
+104.42K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
104.42K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+45K
Price / share
—
Trade value
—
% of position
2715.8%
1/1/2019
1.66K→46.66K
Total
Net shares
+45K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/1/2019 | A · Award | +45K | — | — | 2715.8% | 1.66K | 46.66K |
| Total | +45K | $0.00 | ||||||
Derivative Transactions3
Stock Options (Right to buy)
Direct
Converts to
Common Stock
14.42K shares
Shares
+14.42K
Strike price
2.32
Held after
14.42K
Exercisable
—
1/1/2019
Stock Options (Right to buy)
Direct
Converts to
Common Stock
22.50K shares
Shares
+22.50K
Strike price
2.32
Held after
22.50K
Exercisable
—
1/1/2019
Stock Options (Right to buy)
Direct
Converts to
Common Stock
22.50K shares
Shares
+22.50K
Strike price
2.32
Held after
45K
Exercisable
—
1/1/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (Right to buy) Direct | Common Stock14.42K shares | 1/1/2019 | A · Award | +14.42K | 2.32 | — | 14.42K |
| Stock Options (Right to buy) Direct | Common Stock22.50K shares | 1/1/2019 | A · Award | +22.50K | 2.32 | — | 22.50K |
| Stock Options (Right to buy) Direct | Common Stock22.50K shares | 1/1/2019 | A · Award | +22.50K | 2.32 | — | 45K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned34.96K
Total
34.96K indirect34.96K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 34.96K | Indirect |
| Total | 34.96K | 34.96K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported